Infectious Diseases Unit, Department of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.
Hebrew University School of Medicine, Jerusalem, Israel.
Intern Emerg Med. 2020 Jun;15(4):655-661. doi: 10.1007/s11739-019-02244-8. Epub 2019 Nov 29.
Septic arthritis (SA) is commonly associated with Staphylococcal or Streptococcal infections. Overtime, there has been a global increase in the distribution of antimicrobial resistance within both Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative bacteria such as extended-spectrum beta-lactamase (ESBL) positive Enterobacteriacea. The aim of this study was to determine whether this change in epidemiology similarly affected the distribution of resistant pathogens causing SA. The study was conducted at the Shaare Zedek Medical Center in Jerusalem, Israel. All adult patients diagnosed with SA during 2002-2016 were included in the cohort. Antimicrobial resistance trends were examined over three periods: 2002-2009, 2010-2013, and 2014-2016. Of 85 patients with SA, mean age of patients was 66.8 (± 20.3) years, with male predominance (n = 62, 66%). Most SA cases involved native knee joints and more than 85% (n = 80) were acquired in the community. The most common isolates were S. aureus (n = 38, 45%) and beta-hemolytic streptococci (n = 13, 15%). MRSA SA was diagnosed in 8% of all SA cases (n = 7). An increasing, although non-significant trend in MRSA SA was observed during the study period (p = 0.3). Gram-negative infections were uncommon (n = 14). No ESBL-positive or carbapenem-resistant Enterobacteriacea were detected. Over a 15-year study period, no significant increase in resistant pathogens causing SA was observed. In the era of antibiotic stewardship, these results strengthen our practice of administering narrow-spectrum antimicrobials empirically for SA. However, our findings cannot be generalized to regions with higher rates of MRSA in the community.
脓毒性关节炎(SA)通常与葡萄球菌或链球菌感染有关。随着时间的推移,耐甲氧西林金黄色葡萄球菌(MRSA)等革兰氏阳性菌和产超广谱β-内酰胺酶(ESBL)阳性肠杆菌等革兰氏阴性菌的抗生素耐药性在全球范围内都有所增加。本研究旨在确定这种流行病学的变化是否同样影响引起 SA 的耐药病原体的分布。该研究在以色列耶路撒冷的 Shaare Zedek 医疗中心进行。所有 2002-2016 年期间被诊断为 SA 的成年患者均纳入该队列。研究检查了三个时期的抗生素耐药趋势:2002-2009 年、2010-2013 年和 2014-2016 年。85 例 SA 患者中,患者平均年龄为 66.8(±20.3)岁,男性为主(n=62,66%)。大多数 SA 病例涉及原发性膝关节,85%以上(n=80)在社区获得。最常见的分离物是金黄色葡萄球菌(n=38,45%)和β-溶血性链球菌(n=13,15%)。所有 SA 病例中有 8%(n=7)诊断为 MRSA SA。在研究期间,MRSA SA 的比例呈上升趋势,但无统计学意义(p=0.3)。革兰氏阴性感染少见(n=14)。未检出 ESBL 阳性或碳青霉烯类耐药肠杆菌科。在 15 年的研究期间,未观察到引起 SA 的耐药病原体显著增加。在抗生素管理时代,这些结果支持了我们对 SA 经验性使用窄谱抗生素的实践。然而,我们的发现不能推广到社区中 MRSA 发生率较高的地区。